Augmentin 625 vs Moxikind-CV 625: Amoxicillin + Clavulanic Acid Bioequivalence & Price
Augmentin 625 Duo (GSK) and Moxikind-CV 625 (Mankind Pharma) contain the identical active formulation: Amoxicillin 500mg + Clavulanic Acid 125mg in the gold-standard 4:1 ratio. Both overcome beta-lactamase bacterial resistance to eradicate severe respiratory, sinus, ear, dental, and urinary tract infections. Both deliver identical cure rates and should be taken at the start of a meal. Jan Aushadhi generic tablets save 74% with verified pharmacopoeia standards.
Augmentin 625 Duo
Manufactured by GlaxoSmithKline Pharmaceuticals Ltd (GSK)
Take at the START of a meal to optimize absorption and reduce loose stools
Mild diarrhea / loose stools, Nausea, Vaginal thrush / candidiasis, Mild abdominal cramps
Moxikind-CV 625
Manufactured by Mankind Pharma Ltd
Take with the first bite of a meal
Loose motions, Stomach upset, Skin rash (if allergic)
Key Clinical Differences Between Augmentin 625 Duo and Moxikind-CV 625
- 1. Active Bioequivalence: Both provide 500mg Amoxicillin with 125mg Clavulanic acid. Potassium clavulanate suicide-inhibits bacterial beta-lactamase enzymes, restoring amoxicillin's ability to kill resistant bacteria.
- 2. Manufacturer & Pricing: GSK's Augmentin 625 retails for ~₹220 per strip of 10 tablets. Mankind's Moxikind-CV 625 costs ~₹180 for 10 tablets. At PMBJP Jan Aushadhi Kendras, certified generic Amoxicillin + Clavulanate 625mg costs ₹58.00 (74% savings).
- 3. Gastrointestinal Tolerability: Both brands can cause loose stools due to clavulanic acid accelerating intestinal motility. Co-prescribing probiotics (e.g. Darolac) spaced 2 hours away minimizes diarrhea.
Amoxicillin 500mg + Clavulanic Acid 125mg Tablets IP
Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), bioequivalent generic formulations are available at Kendras across India with 100% bioequivalent clinical therapeutic efficacy.
1. Why Clavulanic Acid is Added to Amoxicillin
Many common bacteria (such as S. aureus, H. influenzae, and E. coli) produce defensive enzymes called beta-lactamases that break apart standard amoxicillin molecules before they can destroy the bacterial cell wall. Potassium clavulanate binds permanently to beta-lactamase enzymes, neutralizing them so amoxicillin can effectively eradicate the infection.
Comprehensive Clinical Pharmacology & Decision Guide: Augmentin 625 Duo vs Moxikind-CV 625
When evaluating Augmentin 625 Duo (Amoxicillin 500mg + Potassium Clavulanate 125mg) against Moxikind-CV 625 (Amoxicillin 500mg + Potassium Clavulanate 125mg), clinicians consider multiple pharmacological parameters including receptor specificity, pharmacokinetic bioavailability, metabolic clearance routes, and potential adverse reactions. The following clinical analysis provides an evidence-based comparison grounded in Indian Pharmacopoeia (IP), National Formulary of India (NFI), and CDSCO regulatory standards.
1. Comparative Mechanism of Action
Augmentin 625 Duo exerts its therapeutic effect through the active pharmaceutical compound Amoxicillin 500mg + Potassium Clavulanate 125mg, targeting specific enzyme or receptor pathways to relieve indicated clinical symptoms. In contrast, Moxikind-CV 625 utilizes Amoxicillin 500mg + Potassium Clavulanate 125mg, which may offer differing therapeutic onset latency, peak plasma concentration, or duration of clinical efficacy depending on patient receptor responsiveness.
2. Pharmacokinetic ADME Profile
Absorption, distribution, metabolism, and excretion (ADME) profiles govern clinical outcomes. Both Augmentin 625 Duo and Moxikind-CV 625 undergo hepatic or renal clearance. Plasma protein binding and elimination half-life ($t_{1/2}$) determine the optimal dosing frequency (e.g., once daily OD vs twice daily BD). Patients with hepatic or renal impairment may require dosage adjustments or increased monitoring.
3. Organ Impairment & High-Risk Precautions
Safety margins differ across patient sub-populations. For patients with reduced estimated Glomerular Filtration Rate (eGFR < 60 mL/min/1.73m²), renal dosage modification may be essential. In hepatic dysfunction (elevated ALT/AST or bilirubin), medications metabolized via Cytochrome P450 enzymes necessitate lower daily thresholds or alternative therapeutic selection.
4. Food & Beverage Interactions
Administration timing relative to meals (empty stomach AC vs post-meal PC) influences gastric tolerance and intestinal absorption. High-fat diets can delay or enhance the absorption of certain lipophilic active salts. Concomitant alcohol consumption must be avoided where hepatotoxicity or central nervous system depression risks exist.
5. Government-Certified Bioequivalent Generic Substitution (PMBJP)
Under the Government of India's Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), bioequivalent generic formulations are produced in WHO-GMP certified facilities with batch-wise NABL testing. Whether opting for Augmentin 625 Duo, Moxikind-CV 625, or an approved Jan Aushadhi generic alternative of identical active salt, clinical bioequivalence ensures identical therapeutic outcomes while reducing prescription costs by up to 90%. Always consult your treating physician or registered pharmacist before switching formulations.
6. Clinical Decision Checklist Before Choosing Between Augmentin 625 Duo and Moxikind-CV 625
- Verify whether your prescription specifies the exact brand or the active salt (Amoxicillin 500mg + Potassium Clavulanate 125mg or Amoxicillin 500mg + Potassium Clavulanate 125mg).
- Check for underlying medical conditions including hypertension, diabetes, peptic ulcers, or renal/hepatic impairment.
- Confirm whether you are taking concurrent medications that share Cytochrome P450 metabolic pathways.
- Ensure dosage strengths match precisely (e.g., tablet mg strength, sustained-release vs immediate-release formulation).
- Store medications in a cool, dry place below 25°C away from direct sunlight and out of reach of children.
Frequently Asked Questions: Augmentin 625 Duo vs Moxikind-CV 625
Q: Is Moxikind-CV 625 as effective as Augmentin 625?
Yes. Both meet rigorous Indian Pharmacopoeia standards for dissolution and chemical purity, yielding identical clinical bacterial eradication rates.
Scan & Compare Any Medicine Pair on MediMatch AI
Use our real-time clinical vision scanner to verify active ingredients, identify dangerous food interactions, and calculate Jan Aushadhi generic savings.
Launch Real-Time Drug Comparator